No effect of intramuscular gold therapy on serological parameters of Helicobacter pylori infection in patients with rheumatoid arthritis: a 12 month prospective study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 8037498.
- Also identified by PMC identifier 1005356.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess prospectively the influence of intramuscular gold therapy on Helicobacter pylori serology in patients with rheumatoid arthritis (RA). Fifty patients with RA were started on intramuscular gold or chloroquine, as the control group and were followed serologically for H pylori infection for 12 months. Twelve patients treated with gold and eight control patients treated with chloroquine, all with serological evidence for H pylori infection, showed no significant decline of IgA and IgG anti-H pylori antibody levels or serum pepsinogen A and C levels. Total serum IgA and IgG levels declined significantly during gold therapy, while they remained unchanged during chloroquine therapy. Intramuscular gold therapy in patients with RA does not influence the serological parameters of H pylori infection.
Medical subject headings
- Antibodies, Bacterial
- Arthritis, Rheumatoid
- Aurothioglucose
- Helicobacter Infections
- Helicobacter pylori
- Immunoglobulin A
- Immunoglobulin G